Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals
Upon antiretroviral therapy (ART) human immunodeficiency virus (HIV)/human T-cell lymphotropic virus type 1 (HTLV-1) co-infected individuals frequently develop neurological disorders through hitherto unknown mechanisms. Here, we show that effective anti-HIV ART increases HTLV-1 proviral load through a polyclonal integration pattern of HTLV-1 in both CD4+ and CD8+ T-cell subsets that is reminiscent of that typically associated with HTLV-1-related inflammatory conditions. These data indicate that preventing ART-triggered clonal expansion of HTLV-1-infected cells in co-infected individuals deserves investigation.
BeilkeM. A., JapaS., Moeller-HadiC., Martin-SchildS.2005; Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. Clin Infect Dis 41:e57–e63 [View Article][PubMed]
BeilkeM. A., Traina-DorgeV. L., SiroisM., BhuiyanA., MurphyE. L., WallsJ. M., FaganR., WinsorE. L., KissingerP. J.2007; Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis 44:1229–1234 [View Article][PubMed]
BergerJ. R., RaffantiS., SvenningssonA., McCarthyM., SnodgrassS., ResnickL.1991; The role of HTLV in HIV-1 neurologic disease. Neurology 41:197–202 [View Article][PubMed]
CavroisM., Wain-HobsonS., WattelE.1995; Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol 146:179–184 [View Article][PubMed]
CavroisM., GessainA., Wain-HobsonS., WattelE.1996; Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 12:2419–2423[PubMed]
CavroisM., GessainA., GoutO., Wain-HobsonS., WattelE.2000; Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 182:1044–1050 [View Article][PubMed]
GessainA., BarinF., VernantJ. C., GoutO., MaursL., CalenderA., de ThéG.1985; Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 326:407–410 [View Article][PubMed]
GilletN. A., MalaniN., MelamedA., GormleyN., CarterR., BentleyD., BerryC., BushmanF. D., TaylorG. P., BanghamC. R.2011; The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117:3113–3122 [View Article][PubMed]
HarrisonL. H., VazB., TaveiraD. M., QuinnT. C., GibbsC. J., de SouzaS. H., McArthurJ. C., SchechterM.1997; Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology 48:13–18 [View Article][PubMed]
LevinM. C., LeeS. M., MorcosY., BradyJ., StuartJ.2002; Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis 186:1514–1517 [View Article][PubMed]
MortreuxF., LeclercqI., GabetA. S., LeroyA., WesthofE., GessainA., Wain-HobsonS., WattelE.2001; Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst 93:367–377 [View Article][PubMed]
MurphyE. L., GrantR. M., KroppJ., OliveiraA., LeeT. H., BuschM. P.2003; Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr 33:655–656 [View Article][PubMed]
SilvaM. T., NevesE. S., GrinsztejnB., de Melo EspíndolaO., SchorD., AraújoA.2012; Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1. AIDS 26:521–523 [View Article][PubMed]
ZaneL., SibonD., MortreuxF., WattelE.2009; Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci 14:3935–3941 [View Article][PubMed]
Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals